Stay updated on Pembrolizumab Neoadjuvant in HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Neoadjuvant in HCC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s revision/version number was updated from v3.5.2 to v3.5.3. This indicates a site build or metadata update without changing the underlying study information presented.
    Difference
    0.1%
    Check dated 2026-04-24T05:47:12.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    System revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:20:47.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    - Added the disease term 'Hepatocellular carcinoma' and a new resource link to the Genetic and Rare Diseases Information Center. - Updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T22:18:54.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T20:04:13.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding lapse notice and Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T06:14:49.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    A government funding/operating status notice was added, with links to cc.nih.gov and opm.gov, and the site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T05:58:07.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Neoadjuvant in HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Neoadjuvant in HCC Clinical Trial page.